The State Administration for Market Regulation has issued guidelines to combat commercial bribery by pharmaceutical companies
Recently, the State Administration for Market Regulation released the "Compliance Guidelines for Pharmaceutical Enterprises to Prevent Commercial Bribery Risks" (hereinafter referred to as t ...
Anti-Corruption 2025-01-15